| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.23 | 3e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-07 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-06 |